Autopsy report · NCT03380104

Intradural Percutaneous Stimulation

“Unable to obtain FDA IDE approval. Currently working on additional preclinical testing.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Matthew Howard

Sponsor type

University, hospital or other

Conditions

Pain, Chronic

Interventions

Intradural Spinal Cord Stimulation; Administration of Questionnaires

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Gastric Restriction Using the EndoSurgical Operating System
  “FDA indicated study should have had prior IDE submission \& approval” (73% match in meaning)
• The Use of Autologous Mesenchymal Stem Cell Preparation for Treatment of Refractory Migraine
  “Pending FDA approval” (70% match in meaning)
• Perceval S Aortic Heart Valve Study- North America
  “FDA approval” (67% match in meaning)
• Electrical Impedence Tomography With ENLIGHT2100
  “Device received FDA approval” (65% match in meaning)
• Safety and Efficacy of Baricitinib for COVID-19
  “Could not make FDA required changes” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.